A newly established venture capital firm based in the USA  just successfully closed the first round of their fund ($20M target), and made its first investment. The firm invests globally in medically related early-stage companies. Initial size of investment ranges from $250 – 500K. While the firm is focused on USA-based companies, the firm is open to considering companies across the globe.

The firm invests in medtech and digital health companies. While the founder has decades of experience as an oculofacial plastic surgeon, the firm is generally opportunistic and will consider any promising technologies that address unmet medical need. The firm has looked at AI companies, digital health/software companies implementable in medical practices, etc. In terms of stage of development, the firm is open to investing as early as pre-prototype, given that the company has properly researched the idea behind their technology.

The firm has no specific company or management team requirements, and is open to acting as either a lead or co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

With about a month left until RESI Boston June 2023 and a few days before partnering launch, LSN is very excited to announce the list of 50+ finalist companies who will be participating in the Innovator’s Pitch Challenge (IPC)!

The deadline was set earlier than our usual IPC application cycles, but the RESI team still received a record number of applications.

Over 50 companies representing therapeutics, medical devices, diagnostics, digital health, and R&D / life science tools across the globe will be delivering a live pitch followed by a Q&A session with a panel of investors and industry experts. In addition, the companies will be presenting a poster showcasing their technology in the exhibit hall. We were very impressed by all of the amazing technologies developed by the IPC finalist companies and we cannot wait to showcase them at the upcoming RESI!

Below are the participating companies. If you are interested in seeing these pitches and engaging in one-on-one partnering with over 1,000 attendees expected to attend, you can register here!

RESI Boston June 2023 IPC Finalists

By Caitlin Dolegowski, Marketing Manager, LSN

RESI Boston, June 5-7 is rapidly approaching, and the partnering platform opens next Monday, May 15. This hybrid conference enables attendees to book meetings either in person on Monday, June 5, or virtually, June 6-7.  The LSN Partnering Platform offers startups the opportunity to search for and identify investors that are a fit for them based on sector, indication, stage of development and other criteria. Successful partnering takes a lot of work, and the companies that book the most meetings send, on average, over 100 meeting requests to relevant investors, followed by frequent follow-ups. We will be offering a free partnering tutorial next week to provide you with helpful insight into making the most of your time at RESI.

There is still time to register for RESI Boston, June 5-7 and meet with 350+ active investors in the life science industry.

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

RESI Boston during BIO week is just a few weeks away. We’ve already told you about the opportunity to meet with 350+ investors and licensing partners and amazing panels and workshops, but you will also be able to meet with some top service providers who may have just the product or service your company needs or will need in the future. RESI is the conference for early-stage partnering, where you can make connections that are focused on this space that you won’t find at other conferences that are geared toward later stage activities.

Here are some of the companies you can meet in the RESI Exhibition Hall this June.

See you in Boston! REGISTER HERE

By Momo Yamamoto, Investor Research Analyst, LSN

Time is flying by, and there is only a month left until RESI Boston! As a refresher, RESI Boston will be a 3-day hybrid conference, taking place on June 5^th – 7^th. June 5^th will be in-person at the Westin Copley Place, featuring Innovator’s Pitch Challenge (IPC) sessions, 7 investor panels, and educational workshops followed by all-day virtual partnering on June 6^th – 7^th.

Life Science Nation is excited to announce the 20+ panelists who have been selected to speak on our investor panels at RESI Boston. Panel topics include: Big Pharma, Women’s Health, Cell & Gene Therapy, Corporate VC, CNS Diseases, Medtech Strategics, and Digital Health. At this RESI, we will be featuring two new panel topics, Women’s Health and CNS Diseases. Join our seasoned panelists from a wide range of sectors to get the latest insight on trends, emerging topics, advice, and more!

Take a look below for our panelists who will be giving you the latest scoop:

Elizabeth Bailey Managing Director RH Capital	Caleb Bell Venture Partner Corundum Systems Biology	Nat Brinn Partner VC23
Frederic Cedrone Vice President, Corporate Innovation Catalent Strategic Ventures	Geoff Dacosta Director, Business Development and Licensing Philips Healthcare	Neel Desai Business Development & Licensing Biogen
Marissa Fayer U.S. Partner Goddess Gaia Ventures	Tom Gibbs Director Debiopharm Innovation Fund	Lucio Iannone VP of Investments Leaps by Bayer
Jotthe Kannappan Associate Intuitive Surgical	Arianne Kidder Principal Seae Ventures	Joan Koerber-Walker Co-Founder and Managing Member AZBio
Adam Kundzewicz Executive Director Boehringer Ingelheim Venture Fund	Linda Li Venture Partner Cleveland Clinic Ventures	Wasim Malik Co-Founder and Managing Partner Iaso Ventures
Amanda Mason Director, Global Head of Inflammation Search & Evaluation, Business Development Amgen	John Pennett Angel Investor Mid Atlantic Bio Angels	Jane Rho Investor, Venture Fund DaVita Venture Group
Ronak Savla Director, Strategic Ventures Catalent Strategic Ventures	Yaniv Sneor Founding Member Mid Atlantic Bio Angels	Ashim Subedee Director, Catalyst Office Division of Research Innovation and Ventures (DRIVe)
David Uffer Vice President, MedTech General Inception	Matt Weinberg Partner Max Ventures	Sonia Weiss Co-Founder & Managing Partner WPSS.bio
Andrew Wong Global Head of Bayer CoLabs Bayer	Lu Zhang Managing Partner Fusion Fund

By Antoinette Lowre, Manager of Business Development, LSN

The AAP is a cost-effective way to attend RESI Boston on Monday, June 5^th, and network with over 600 early-stage life science startups, investors, and strategic partners. With an AAP, you can join all the live sessions including the Innovator’s Pitch Challenge, investor panels and entrepreneur workshops. This registration option does not include partnering but allows you to take advantage of the educational component of RESI along with the collision factor we see at all our in-person events.

Check out our agenda for Monday, June 5

You can also view the investors who are attending RESI Boston June on our RESI Conference Website which we update frequently so you know who will be a good fit for you to meet in June.

Investor Panel

Innovator’s Pitch Challenge

Entrepreneur Workshop

Want to learn more about RESI and how you can take advantage of the AAP? Reach out to your BD manager and we’d love to answer any questions you may have and learn more about your startup company’s fundraising goals.

Life Science Nation Business Development Team
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast  (USA)
Greg Mannix Vice President International Business Development Book a Meeting Email Me	Candice He VP, Business Development & Global Investment Strategist Book a Meeting Email Me	Antoinette Lowre Manager of Business Development Book a Meeting Email Me	Cameron Hurlburt Manager of Business Development Book a Meeting Email Me

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

Don’t miss your chance to interact with tech hubs at RESI Boston in June. Tech hubs are a crucial part of the Life Science Nation (LSN) and RESI community as they provide capital, entrepreneurial support, lab space, and economic development for their cohort of aspiring scientist-entrepreneur and fundraising executives. With this immense support from tech hubs, their group of startups, who’ve raised less than $2M USD, can accelerate their entrepreneurship journey by participating in RESI at a discounted rate and taking advantage of LSN services. Ranging from universities, non-profits, incubators, accelerators, and regional and government organizations, they are all looking to connect with investors, strategic partners, and early-stage life science startups in Boston.

Don’t see your organization on this list? Contact us to learn more about the Super Early Bird rate and discounted sponsorship levels for your tech hub and startups.

RESI Boston June 2023 Featured Tech Hubs